Tokishakuyakusan suppresses endometriosis and may be associated with improved fertility during attempts to conceive: A mouse model study

Eiko Maki, Maki E, Izumi G, Gentaro Izumi, Kaori Koga, Koga K, Mohammed Elsherbini, Elsherbini M, Arisa Takeuchi, Takeuchi A, Makabe T, Tomoko Makabe, Ayumi Taguchi, Taguchi A, Tokita Y, Yohei Tokita, Marie Hamaguchi, Hamaguchi M, Tetsuya Hirata, Hirata T, Hirota Y, Yasushi Hirota, Yutaka Osuga, Osuga Y
Journal of Reproductive Immunology · 2026 · vol. 176 , pp. 104933 · doi:10.1016/j.jri.2026.104933 · PMID:42418937 · W7166684423
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-20 ⓘ

Tokishakuyakusan treatment in a mouse model reduced endometriosis lesion size and inflammatory cytokines, tending to shorten time to pregnancy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Tokishakuyakusan (TSS), a traditional Japanese Kampo medicine, is known for its anti-inflammatory and anti-angiogenic properties. This study examined the effects of TSS on fecundity and endometriosis-like lesions during pregnancy in a murine model of endometriosis. Endometriosis model mice were divided into four groups: Sham operation + control diet (Sham/Cont), Sham operation + 3% TSS diet (Sham/TSS), Endometrium dispersion + control diet (End/Cont), and Endometrium dispersion + 3% TSS diet (End/TSS). Mating was initiated one day after surgery, and females were sacrificed on postpartum day 3. Endometriosis-like lesion size, inflammatory cytokine levels, and reproductive outcomes were evaluated. Time to delivery tended to be shorter in the End/TSS group than in the End/Cont group (median: 23.5 vs. 27 days), although the difference was not statistically significant. The maximum lesion diameter in the End/TSS group was significantly smaller compared to the End/Cont group (median: 4.54 mm vs. 7.76 mm, p = 0.044). Concentrations of the inflammatory cytokines MIP-3α and IL-17A were significantly lower in the End/TSS group (MIP-3α: 14.54 [12.91, 18.98] vs. 25.26 [16.81, 48.58] pg/mg protein, p = 0.019, IL-17A: 10.00 [9.05, 18.76] vs. 19.06 [16.75, 82.81] pg/mg protein, p = 0.019). TSS administration reduced endometriosis-like lesion size and was associated with suppression of Th17-related inflammatory mediators in a murine model of endometriosis. Consequently, the administration of TSS tended to shorten the time to pregnancy. These findings suggest that TSS may exert immunomodulatory effects within endometriosis lesions and could represent a potential non-hormonal therapeutic approach during the peri-conceptional period.

My notes (saved in your browser only)

MeSH descriptors

Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

SciLite annotations

organisms 2
transgenic mice mus sp.

Source provenance

europepmc
last seen: 2026-09-03T06:15:13.668130+00:00
openalex
last seen: 2026-09-03T06:07:24.514690+00:00
pubmed
last seen: 2026-09-03T06:09:27.026810+00:00
scilite
last seen: 2026-08-02T09:40:10.667495+00:00
License: CC0 · commercial use OK